Itopride for stomach issues from semaglutide in diabetic women
Part of Digestive system clinical trials.
This trial tests if itopride can help with stomach problems caused by semaglutide in diabetic women having a hysterectomy. It aims to see if this combination can improve symptoms like slow stomach emptying.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 40 and 60 years old.
- Your BMI is between 20 and 30.
- You have diabetes and take semaglutide (0.5 to 1 mg) as a weekly injection under the skin.
- You are scheduled for a planned hysterectomy (surgery to remove the uterus).
- You are considered a low to moderate risk for surgery (ASA grade I to III).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a non-invasive test (body surface gastric mapping) to look at stomach activity in people taking semaglutide. It aims to understand how the medicine affects digestion.
This trial tests if a medicine called itopride can help people with functional dyspepsia (a condition where the stomach feels full, bloated, or painful after meals without a clear cause). It aims to find out if it improves symptoms like postprandial distress (discomfort after eating).
This trial tests two medicines (itopride and metoclopramide) to see which works better for emptying the stomach in hospitalized patients who are fed through a tube and have a large amount of fluid left in their stomach.
This study compares two medicines, Acotiamide and Itopride, to see which works better for treating indigestion (feeling full too quickly after meals). It may help if your stomach symptoms are bothersome and not caused by another illness.
This trial studies whether semaglutide can help women with prediabetes after past gestational diabetes return to better blood sugar levels and lower progression to diabetes. It is designed for women who are no longer breastfeeding and can use effective birth control.
This trial tests if a new stomach acid blocker (vonoprazan) works better alone or with a medicine that helps stomach movement (itopride) for people with ongoing stomach discomfort. It aims to find a better treatment for functional dyspepsia.
Hear when a new Semaglutide-Induced Gastric Motility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.